MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$2,788K
Free Cash flow
-$18,482K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from the issuance of de...
Proceeds from issuance of common...
Equity-based compensation
Others
Negative Cash Flow Breakdown
Change in fair value of warrants
Net loss
Accrued expenses and other curre...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Net loss
-8,378
-48,638
Depreciation
61
125
Equity-based compensation
1,476
3,176
Non-cash interest expense
886
253
Amortization of right of use lease asset
169
336
Foreign currency loss (gain)
98
-479
Change in fair value of warrants
-9,846
2,587
Prepaid expenses and other current assets
975
636
Other non-current assets
13
882
Accounts payable
50
877
Lease liability
-139
-418
Accrued expenses and other current liabilities
-1,671
-152
Net cash used in operating activities
-18,478
-42,893
Purchase of property and equipment
4
54
Net cash used in investing activities
-4
-54
Proceeds from the issuance of debt
14,714
11,720
Payments of debt issuance costs
18
233
Proceeds from issuance of common stock upon exercise of stock options
2
-
Proceeds from issuance of common stock in connection with at-the-market program, net of issuance costs of 134
6,572
-
Net cash provided by financing activities
21,270
11,487
Net decrease in cash, cash equivalents and restricted cash
2,788
-31,460
Effect of exchange rate changes on cash
-695
-
Cash and cash equivalents at beginning of period
60,299
-
Cash and cash equivalents at end of period
30,932
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from the
issuance of debt
$14,714K
Proceeds from issuance of
common stock in...
$6,572K
Proceeds from issuance of
common stock upon...
$2K
Net cash provided by
financing activities
$21,270K
Canceled cashflow
$18K
Net decrease in
cash, cash...
$2,788K
Canceled cashflow
$18,482K
Payments of debt issuance
costs
$18K
Equity-based compensation
$1,476K
Non-cash interest
expense
$886K
Amortization of right of use
lease asset
$169K
Depreciation
$61K
Accounts payable
$50K
Net cash used in
operating activities
-$18,478K
Net cash used in
investing activities
-$4K
Canceled cashflow
$2,642K
Change in fair value of
warrants
-$9,846K
Net loss
-$8,378K
Accrued expenses and
other current...
-$1,671K
Purchase of property and
equipment
$4K
Prepaid expenses and
other current assets
$975K
Lease liability
-$139K
Foreign currency loss
(gain)
$98K
Other non-current
assets
$13K
Buy us a coffee
IO Biotech, Inc. (IOBT)
IO Biotech, Inc. (IOBT)